SBI Securities’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$31K Buy
15,793
+809
+5% +$1.9K ﹤0.01% 1289
2025
Q4
$40.6K Sell
14,984
-5,098
-25% -$16.7K ﹤0.01% 1162
2025
Q3
$84.9K Sell
20,082
-1,460
-7% -$6.42K ﹤0.01% 903
2025
Q2
$107K Sell
21,542
-1,082
-5% -$4.7K ﹤0.01% 792
2025
Q1
$99.8K Buy
22,624
+2,748
+14% +$12.9K ﹤0.01% 750
2024
Q4
$92.4K Buy
+19,876
New +$109K ﹤0.01% 784

Other funds holding GDRX

SBI Securities's GDRX Position: Q1 2026 in Review

SBI Securities increased its GoodRx Holdings (GDRX) stake by 5.4% in Q1 2026, buying an estimated $1.9K and bringing the position to 15,793 shares worth $31K. The position accounts for ﹤0.01% of the portfolio, ranked #1289.

SBI Securities first reported a position in GDRX in Q4 2024 and has held it in 6 quarters since. The position peaked at $107K in Q2 2025. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • SBI Securities held 15,793 shares of GoodRx Holdings worth $31K as of Q1 2026.
  • SBI Securities bought 809 GoodRx Holdings shares in Q1 2026, an estimated $1.9K.
  • GoodRx Holdings made up ﹤0.01% of SBI Securities's portfolio in Q1 2026, its #1289 holding.
  • SBI Securities first reported a position in GoodRx Holdings in Q4 2024 and has held it in 6 quarters since.
  • SBI Securities's GoodRx Holdings position peaked at $107K in Q2 2025.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.